The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Large Is The Pharmaceutical Stability And Storage Services Market Projected To Become By 2030 Based On Its 2026 Valuation?
The pharmaceutical stability and storage services market has demonstrated robust growth in recent years. This market is projected to expand from $2.81 billion in 2025 to $2.99 billion in 2026, progressing at a compound annual growth rate (CAGR) of 6.1%. The historical expansion can be attributed to stringent pharmaceutical regulatory mandates, an increase in global drug production, the proliferation of biologics manufacturing, the essential need for shelf-life validation, and rising volumes of clinical trials.
The pharmaceutical stability and storage services market size is projected to experience robust expansion over the coming years. This market is anticipated to reach a valuation of $3.78 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.1%. Factors driving this anticipated growth include an increase in biologics and cell therapies, the growing trend of pharmaceutical outsourcing, the broadening of global cold chain infrastructure, heightened vaccine manufacturing, and more stringent regulatory oversight concerning drug stability. Significant trends predicted for the forecast timeframe encompass an escalating demand for storage that complies with regulations, a surge in the outsourcing of stability testing services, an expanding requirement for cold chain and cryogenic storage solutions, the broadening of stability services tailored for biologics, and an intensified emphasis on ensuring long-term drug quality.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=23473&type=smp
What Drivers Are Shaping The Future Growth Of The Pharmaceutical Stability And Storage Services Market?
The expanding volume of new drug endorsements is anticipated to fuel the expansion of the pharmaceutical stability and storage services market in the future. A novel drug is defined as a pharmaceutical compound recently created and not previously sanctioned for utilization or commercialized. This rise in novel drug approvals stems from progress in biotechnology, which allows for the identification of new compounds, coupled with enhanced regulatory procedures that streamline drug development, making it quicker and more effective. Consequently, the growing frequency of novel drug approvals boosts the need for pharmaceutical stability and storage services, which are crucial for maintaining optimal conditions, ensuring regulatory compliance, and managing extended product shelf-life. To illustrate, data from the U.S. Food and Drug Administration (FDA), a federal agency in the US tasked with safeguarding public health, indicates that in October 2023, the FDA sanctioned 37 novel drugs in 2022, with a subsequent 50 approved in 2024. These approvals advanced treatments for various conditions including cancer, rare diseases, neurological disorders, infections, and ailments such as schizophrenia, pain, and Alzheimer’s. Hence, the increasing number of novel drug approvals significantly contributes to the growth of the pharmaceutical stability and storage services market.
What Segment Groups Are Identified Within The Pharmaceutical Stability And Storage Services Market?
The pharmaceutical stability and storage services market covered in this report is segmented –
1) By Service: Stability, Storage
2) By Product Type: Tablets, Capsules, Injectable Solutions, Oral Suspensions, Combination Products, Other Product Types
3) By Molecule: Small Molecule, Large Molecule
4) By Mode: In-House, Outsourcing
5) By End User: Biopharmaceutical Companies, Contract Manufacturing Organizations, Contract Research Organizations, Other End Users
Subsegments:
1) By Stability Services: Long-Term Stability Studies, Accelerated Stability Studies, Intermediate Stability Studies, Photostability Testing, Forced Degradation Studies
2) By Storage Services: Ambient Storage, Refrigerated Storage (2°C to 8°C), Frozen Storage (-20°C to -80°C), Cryogenic Storage (-150°C to -196°C), Controlled Drug Substance And Product Storage
What Trends Are Advancing Progress In The Pharmaceutical Stability And Storage Services Market?
Leading companies in the pharmaceutical stability and storage services market are prioritizing the development of technologically advanced solutions, such as cryogenic storage suites, to enhance the preservation of temperature-sensitive pharmaceutical products. Cryogenic storage suites are specialized facilities designed to maintain extremely low temperatures, typically below -150°C, essential for safeguarding delicate biological and pharmaceutical materials like cell therapies, vaccines, and biologics. For instance, in December 2024, Astoriom, a UK-based stability and biospecimen storage industry player, launched a cryogenic storage suite at its Tramore facility in County Waterford, Ireland, considerably expanding its capabilities for biological sample storage. This advanced suite is engineered to meet the growing demand for secure, long-term preservation of biological materials, ensuring their viability over extended periods. The storage boasts precise temperature control down to -196°C, extensive storage capacity, ISO 9001 certification for regulatory compliance, and robust security measures, including access controls and monitoring systems.
Which Companies Hold Significant Positions In The Pharmaceutical Stability And Storage Services Market?
Major companies operating in the pharmaceutical stability and storage services market are SGS S.A., Eurofins Scientific SE, Intertek Group plc, Catalent Inc., Almac Group, Alcami Corporation, Reading Scientific Services Ltd., Charles River Laboratories, Element Materials Technology Inc., Precision Stability Storage, Roylance Stability Storage Limited, BioLife Solutions Inc., Alloga UK Ltd., Auriga Research Private Limited, Q Laboratories Inc., ALS Limited, Lucideon Limited, Cencora Inc., PCI Pharma Services, DHL Life Sciences & Healthcare
Read the full pharmaceutical stability and storage services market report here:
Which Geographic Regions Are Influencing Demand In The Pharmaceutical Stability And Storage Services Market?
North America was the largest region in the pharmaceutical stability and storage services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical stability and storage services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Pharmaceutical Stability And Storage Services Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=23473&type=smp
Browse Through More Reports Similar to the Global Pharmaceutical Stability And Storage Services Market 2026, By The Business Research Company
Pharmacy Repackaging Systems Market Report 2026
https://www.thebusinessresearchcompany.com/report/pharmacy-repackaging-systems-global-market-report
Temperature Controlled Pharmaceutical Containers Market Report 2026
Pharmaceutical Packaging Equipment Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model